Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8 + T Cells

Title
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8 + T Cells
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 76, Issue 2, Pages 264-274
Publisher
American Association for Cancer Research (AACR)
Online
2016-01-12
DOI
10.1158/0008-5472.can-15-1567

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started